CYCLOPHOSPHAMIDE Safety Questions, CYCLOPHOSPHAMIDE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CYCLOPHOSPHAMIDE. Our extensive database of CYCLOPHOSPHAMIDE adverse events and CYCLOPHOSPHAMIDE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE Safety Reports
Total CYCLOPHOSPHAMIDE reports: 525.CYCLOPHOSPHAMIDE FDA safety alerts: No.
Reported deaths: 83 Reported hospitalizations: 320.
Take CYCLOPHOSPHAMIDE Side Effects Survey or Share Your CYCLOPHOSPHAMIDE Story. CYCLOPHOSPHAMIDE Usage.
< Previous Showing 151-225 of 525 Next >
Health Professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on May 09, 2007. Female patient, 47 years of age, was diagnosed with breast cancer, maintenance of anaesthesia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN, DESFLURANE, REMIFENTANIL. Patient recovered.CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Female patient, weighting 173.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CYCLOPHOSPHAMIDE dosage: 1170 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 10, 2007. Female patient, weighting 132.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: brain herniation, brain oedema, hypotension, subarachnoid haemorrhage, tachycardia. CYCLOPHOSPHAMIDE dosage: 2052 MG. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE SULPHATE, ALLOPURINOL. Patient was hospitalized. Patient died on 05/06/2007.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Male patient, weighting 147.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pyrexia. CYCLOPHOSPHAMIDE dosage: 1365 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, ACETAMINOPHEN, ATORVASTATIN CALCIUM, CLONAZEPAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 09, 2007. Male patient, weighting 198.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anorectal cellulitis, candidiasis, corynebacterium infection, culture positive, enterococcal infection, hydrocele, myositis, oedema, scrotal oedema. CYCLOPHOSPHAMIDE dosage: 2100 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN CALCIUM, MESNA, METHOTREXATE, PREDNISONE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Female patient, weighting 213.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: clostridium difficile toxin test positive, decreased appetite, fatigue, febrile neutropenia. CYCLOPHOSPHAMIDE dosage: 1230 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, LIPITOR, LEVOTHYROXINE, TOPROL, FISH OIL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 09, 2007. Male patient, 39 years of age, weighting 176.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 7300MG ONCE IV DRIP. During the same period patient was treated with MESNA, ATRIPLA, ATIVAN, AMBIEN. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Male patient, weighting 194.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, epistaxis, lung disorder, lymphadenopathy, mucosal inflammation, pancytopenia, pulmonary hypertension, pyrexia, treatment noncompliance. CYCLOPHOSPHAMIDE dosage: 2000 MG. During the same period patient was treated with CYTARABINE, DOXORUBICIN HYDROCHLORIDE, LEUCOVORIN CALCIUM, METHOTREXATE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 11, 2007. Male patient, weighting 154.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, pelvic venous thrombosis. CYCLOPHOSPHAMIDE dosage: 2280 MG. During the same period patient was treated with DAUNORUBICIN, DEXAMETHASONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on May 14, 2007. Female patient, 59 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, chronic myelomonocytic leukaemia, hypogammaglobulinaemia, thrombocytopenia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
Health Professional from reported CYCLOPHOSPHAMIDE problem on Jan 31, 2007. Male patient, 40 years of age, was diagnosed with scleroderma, sinusitis, arthralgia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: hepatitis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with CORTICOSTEROID, DEPEN. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on May 15, 2007. Female patient, 59 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, chronic myelomonocytic leukaemia, hypogammaglobulinaemia, thrombocytopenia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
Health Professional from SWITZERLAND reported CYCLOPHOSPHAMIDE problem on May 01, 2006. Female patient, 66 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: venoocclusive liver disease. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with ROXITHROMYCIN. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from SWITZERLAND on May 01, 2006. Female patient, 66 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: venoocclusive liver disease. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with ROXITHROMYCIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 03, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia. CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
CYCLOPHOSPHAMIDE problem was reported by a Physician from UNITED STATES on May 03, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia. CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
Physician from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 03, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia. CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
CYCLOPHOSPHAMIDE problem was reported by a Physician from UNITED STATES on May 03, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia. CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 10, 2007. Male patient, 73 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: diplopia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MABTHERA, MITOXANTRONE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on May 15, 2007. Female patient, 62 years of age, was diagnosed with diffuse large b-cell lymphoma, granulocyte count decreased and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, convulsion, dehydration, diarrhoea, hypertension, lethargy, leukoencephalopathy, nausea. CYCLOPHOSPHAMIDE dosage: 750 MG/M2. During the same period patient was treated with PREDNISONE, RITUXIMAB, DOXORUBICIN, VINCRISTINE, FILGRASTIM. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 17, 2007. Female patient, weighting 152.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood albumin decreased, hypotension, neutropenic sepsis, respiratory failure, septic embolus. CYCLOPHOSPHAMIDE dosage: 1992 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient, weighting 133.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile neutropenia, granulocyte count decreased, platelet count decreased, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 966 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 17, 2007. Female patient, weighting 176.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: full blood count abnormal. CYCLOPHOSPHAMIDE dosage: 1100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Male patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: candidiasis, ear pain, fatigue, febrile neutropenia, mucosal inflammation, pharyngolaryngeal pain, pneumonia primary atypical, pulmonary oedema, sinusitis. CYCLOPHOSPHAMIDE dosage: 1148 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, BACTRIM, NYSTATIN, PREVACID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on May 15, 2007. Female patient, 59 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, chromosome abnormality, chronic myelomonocytic leukaemia, cushingoid, pallor, platelet count decreased, thrombocytopenia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on May 23, 2007. Female patient, 47 years of age, was diagnosed with breast cancer, maintenance of anaesthesia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN, DESFLURANE, REMIFENTANIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 21, 2007. Male patient, weighting 147.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chest x-ray abnormal, computerised tomogram abnormal, pyrexia. CYCLOPHOSPHAMIDE dosage: 1365 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, ACETAMINOPHEN, ATORVASTATIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Male patient, weighting 167.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, duodenal ulcer, duodenitis, fatigue, haematemesis, melaena, oesophageal candidiasis. CYCLOPHOSPHAMIDE dosage: 1507 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, HYDROCODONE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 16, 2006. Female patient, 39 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: sepsis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOCETAXEL, ADRIAMYCIN PFS. Patient died on 01/01/2006.
CYCLOPHOSPHAMIDE problem was reported by a Pharmacist from UNITED STATES on Feb 19, 2007. Female patient, 20 years of age, was diagnosed with systemic lupus erythematosus and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: extravasation. CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 24, 2007. Female patient, weighting 140.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomegaly, deep vein thrombosis, escherichia infection, hypotension, lung infiltration, pulmonary hypertension, respiratory failure. CYCLOPHOSPHAMIDE dosage: 820 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ARANESP. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on May 24, 2007. Female patient, 38 years of age, was diagnosed with hiv test positive and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: herpes zoster, rash vesicular. CYCLOPHOSPHAMIDE dosage: 650 MG DAY 1 AND DAY 8. During the same period patient was treated with ADRIAMYCIN PFS, VINCRISTINE, PREDNISOLONE, LAMIVUDINE, NEVIRAPINE, STAVUDINE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on May 23, 2007. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pyrexia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, NEULASTA, EPIRUBICIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, weighting 180.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chest pain, chronic obstructive pulmonary disease, cough, depressed level of consciousness, musculoskeletal pain, neutropenia, pleuritic pain, sputum purulent. CYCLOPHOSPHAMIDE dosage: 1122 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, DEXAMETHASONE, NEULASTAECTION. Patient was hospitalized. Patient died on 05/22/2007.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 29, 2007. Male patient, weighting 169.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal tenderness, bowel sounds abnormal, infusion related reaction, obstruction, renal failure acute, suprapubic pain, tumour lysis syndrome, urinary retention. CYCLOPHOSPHAMIDE dosage: 1440 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, weighting 198.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, gastrointestinal disorder, loss of consciousness, nausea, pulmonary oedema, tachypnoea. CYCLOPHOSPHAMIDE dosage: 4200 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, BACTRIM DS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 31, 2007. Female patient, weighting 133.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, platelet count decreased, urinary tract disorder. CYCLOPHOSPHAMIDE dosage: 966 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, weighting 161.8 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, blood pressure inadequately controlled, bone marrow failure, febrile neutropenia, mucosal inflammation, muscular weakness, performance status decreased. CYCLOPHOSPHAMIDE dosage: 1320 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 01, 2007. Male patient, weighting 167.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, duodenal ulcer, duodenitis, fatigue, haematemesis, helicobacter infection, melaena, oesophageal candidiasis. CYCLOPHOSPHAMIDE dosage: 1507 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, HYDROCODONE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2007. Male patient, weighting 240.5 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYCLOPHOSPHAMIDE dosage: 1392 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, ATIVAN, DEPAKOTE, LORTAB. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 04, 2007. Female patient, weighting 214.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood culture positive, breast abscess, breast cellulitis, breast induration, haematoma, haemoglobin decreased, malaise. CYCLOPHOSPHAMIDE dosage: 1236 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, weighting 161.8 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, blood electrolytes abnormal, bone marrow failure, fatigue, febrile neutropenia, hypertension, mucosal inflammation, muscular weakness, performance status decreased. CYCLOPHOSPHAMIDE dosage: 1320 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Health Professional from ITALY reported CYCLOPHOSPHAMIDE problem on June 05, 2007. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, neuropathy peripheral. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, TAMOXIFEN CITRATE, EPIRUBICIN, FLUOROURACIL, EXEMESTANE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Male patient, 35 years of age, weighting 110.2 lb, was diagnosed with lupus nephritis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: gingivitis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, VITAMIN E. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 05, 2007. Female patient, weighting 250.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, body temperature increased, groin abscess, infection, neutropenia, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1296 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Male patient, weighting 240.5 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: dysphagia, febrile neutropenia, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1392 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, ATIVAN, DEPAKOTE, LORTAB. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 06, 2007. Male patient, 22 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, malignant melanoma. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, ASPARAGINASE, DAUNORUBICIN, MERCAPTOPURINE, PREDNISONE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2007. Male patient, 35 years of age, weighting 110.2 lb, was diagnosed with lupus nephritis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: gingivitis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, VITAMIN E. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 08, 2007. Female patient, weighting 172.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Female patient, weighting 264.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cough, febrile neutropenia, nausea, otitis media, throat irritation, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1320 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ACTOS, ASPIRIN, BENICAR, DECADRON, FOSAMAX, GLIPIZIDE, LORAZEPAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 14, 2007. Female patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, pyrexia. CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient, weighting 202.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, clostridial infection, deep vein thrombosis, febrile neutropenia, pseudomonas infection, pulmonary embolism. CYCLOPHOSPHAMIDE dosage: 1230 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, LIPITOR, METRONIDAZOLE, TOPROL, ZANTAC. Patient was hospitalized. Patient recovered.
Health Professional from ITALY reported CYCLOPHOSPHAMIDE problem on June 18, 2007. Female patient, child 9 years of age, was diagnosed with aplastic anaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, graft versus host disease, miller fisher syndrome. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, ANTITHYMOCYTE GLOBULIN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HEMATOPOETIC PROGENITOR CELLS. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 18, 2007. Female patient, weighting 138.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, stomatitis. CYCLOPHOSPHAMIDE dosage: 1215 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, HEPARIN LOCK, HYDROCHLOROTHIAZIDE, LEVAQUIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 12, 2007. Male patient, 58 years of age, was diagnosed with lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: metastasis, prostate cancer, prostatic specific antigen increased. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, PREDNISOLONE, MABTHERA. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, weighting 205.9 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. CYCLOPHOSPHAMIDE dosage: 4800 MG. During the same period patient was treated with TAXOTERE, DOXORUBICIN HYDROCHLORIDE, ASPIRIN, CELEBREX, COREG, FEMARA, LIPITOR, LISINOPRIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 20, 2007. Female patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: computerised tomogram thorax abnormal, cough, haemoglobin abnormal, hypoxia, pyrexia. CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Female patient, weighting 152.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bacteraemia, blood lactic acid increased, bowel sounds abnormal, cardio-respiratory arrest, feeding disorder, fungaemia, herpes zoster. CYCLOPHOSPHAMIDE dosage: 1992 MG. During the same period patient was treated with DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE, ALLOPURINOL. Patient died on 06/04/2007.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 19, 2007. Male patient, weighting 194.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, cardiac failure congestive, congestive cardiomyopathy, hyperkalaemia, renal failure acute, staphylococcal infection. CYCLOPHOSPHAMIDE dosage: 2090 MG. During the same period patient was treated with CYTARABINE, METHOTREXATE. Patient was hospitalized. Patient died on 01/10/2007.
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from ITALY on June 20, 2007. Female patient, child 9 years of age, was diagnosed with aplastic anaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, graft versus host disease, miller fisher syndrome. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, ANTITHYMOCYTE GLOBULIN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HEMATOPOETIC PROGENITOR CELLS. Patient recovered.
Health Professional from ITALY reported CYCLOPHOSPHAMIDE problem on June 22, 2007. Female patient, 59 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, neuropathy peripheral. CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Female patient, weighting 163.8 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYCLOPHOSPHAMIDE dosage: 1030 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on June 18, 2007. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pyrexia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, NEULASTA, EPIRUBICIN, FLUOROURACIL, ONDANSETRON, DEXAMETHASONE, AMLODIPINE, PRAVASTATIN. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Male patient, 21 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: azoospermia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with LASTET, METHOTREXATE, CYLOCIDE, LEUKERIN, DAUNOMYCIN, ONCOVIN, LEUNASE, ADRIAMYCIN PFS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 20, 2007. Male patient, 60 years of age, was diagnosed with leukaemia, prophylaxis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction, rash erythematous, toxic skin eruption. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PRAVASTATIN, FLUDARA, ZELITREX, PLAVIX, BACTRIM. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2007. Female patient, weighting 150.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: nausea, oral intake reduced, vomiting. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Health Professional from AUSTRALIA reported CYCLOPHOSPHAMIDE problem on June 07, 2006. Male patient, 45 years of age, weighting 194.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: migraine. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, weighting 166.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumonia. CYCLOPHOSPHAMIDE dosage: 700 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, BACTRIM DS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 11, 2006. Male patient, weighting 9.48 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bowel sounds abnormal, clostridial infection, disease progression, gastrointestinal haemorrhage, hypotension, lower gastrointestinal haemorrhage, necrotising fasciitis, neutropenic sepsis. CYCLOPHOSPHAMIDE dosage: 250 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, VINCRISTINE, ALLOPURINO. Patient was hospitalized. Patient died on 07/03/2006.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Female patient, weighting 50.04 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, body temperature increased, cardiac arrest, hypotension, laceration, limb injury, neutropenia, pseudomonas infection, respiratory rate increased. CYCLOPHOSPHAMIDE dosage: 800 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, METHOTREXATE, THIOGUANINE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 14, 2006. Female patient, weighting 170.9 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, blood bilirubin increased, cardiac tamponade, central line infection, computerised tomogram abdomen abnormal, depressed level of consciousness, dialysis, disseminated tuberculosis. CYCLOPHOSPHAMIDE dosage: 1860 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, MERCAPTOPURINE, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, weighting 178.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: back pain, bone pain, haematocrit decreased, haemoglobin decreased. CYCLOPHOSPHAMIDE dosage: 1760 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Health Professional from ITALY reported CYCLOPHOSPHAMIDE problem on Oct 24, 2005. Male patient, 63 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: hepatitis b, multi-organ failure, secondary immunodeficiency. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient died on 10/01/2004.
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, weighting 176.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, bacterial sepsis, haemodialysis, neutropenia, pyrexia, renal failure, urosepsis. CYCLOPHOSPHAMIDE dosage: 1860 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, THIOGUANINE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Health Professional from GERMANY reported CYCLOPHOSPHAMIDE problem on Feb 28, 2006. Female patient, 57 years of age, weighting 185.2 lb, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: dizziness, febrile neutropenia, neuralgia, pneumonia, viral infection. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN, TAVANIC, EPOETIN BETA, NEULASTA. Patient was hospitalized. Patient recovered.
< Previous Showing 151-225 of 525 Next >
This
drug has an active FDA Safety Alert